Published in J Antimicrob Chemother on February 01, 1998
Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States. Antimicrob Agents Chemother (2000) 1.11
Escherichia coli ATCC 35218 as a quality control isolate for susceptibility testing of Haemophilus influenzae with haemophilus test medium. Antimicrob Agents Chemother (1999) 0.82
Use of next generation sequence to investigate potential novel macrolide resistance mechanisms in a population of Moraxella catarrhalis isolates. Sci Rep (2016) 0.79
Relationship between antibiotic resistance in Streptococcus pneumoniae and that in Haemophilus influenzae: evidence for common selective pressure. Antimicrob Agents Chemother (2002) 0.79
Pneumonia caused by Moraxella catarrhalis in haematopoietic stem cell transplant patients. Report of two cases and review of the literature. Libyan J Med (2007) 0.76
Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro and in vivo in various extraintestinal Escherichia coli isolates. Microb Pathog (1990) 3.18
Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells. Infect Immun (1992) 2.69
Detection of legionellae in hospital water samples by quantitative real-time LightCycler PCR. Appl Environ Microbiol (2001) 2.43
Ochrobactrum anthropi bacteremia: report of four cases and short review. Infection (1994) 2.13
Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J (2008) 1.97
Pulsed field electrophoresis of genomic restriction fragments for the detection of nosocomial Legionella pneumophila in hospital water supplies. J Clin Microbiol (1991) 1.89
Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia. Eur J Clin Microbiol Infect Dis (2005) 1.83
CRB-65 predicts death from community-acquired pneumonia. J Intern Med (2006) 1.61
Infection of Acanthamoeba castellanii by Chlamydia pneumoniae. Appl Environ Microbiol (1997) 1.55
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors. Eur Respir J (2009) 1.54
Aggregation substance promotes adherence, phagocytosis, and intracellular survival of Enterococcus faecalis within human macrophages and suppresses respiratory burst. Infect Immun (2000) 1.53
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother (1994) 1.49
gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli. J Antimicrob Chemother (1996) 1.48
Staphylococcus saprophyticus urease: characterization and contribution to uropathogenicity in unobstructed urinary tract infection of rats. Infect Immun (1989) 1.47
Cloning and genetic characterization of the flagellum subunit gene (flaA) of Legionella pneumophila serogroup 1. Infect Immun (1995) 1.47
[New therapeutic strategies for community acquired pneumonia]. Internist (Berl) (2005) 1.43
Cloning and expression of Staphylococcus saprophyticus urease gene sequences in Staphylococcus carnosus and contribution of the enzyme to virulence. Infect Immun (1989) 1.43
Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model. Infect Immun (1986) 1.43
Genome analysis of Legionella ssp. by orthogonal field alternation gel electrophoresis (OFAGE). FEMS Microbiol Lett (1990) 1.39
The lipopolysaccharide of Legionella pneumophila serogroup 1 (strain Philadelphia 1): chemical structure and biological significance. Prog Clin Biol Res (1995) 1.37
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J (2007) 1.34
Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis (2007) 1.31
Overexpresssion of a Legionella pneumophila homologue of the E. coli regulator csrA affects cell size, flagellation, and pigmentation. Int J Med Microbiol (2001) 1.29
Properties of Escherichia coli strains of serotype O6. Infection (1996) 1.26
Reciprocal exchange of minor components of type 1 and F1C fimbriae results in hybrid organelles with changed receptor specificities. J Bacteriol (1994) 1.23
Temperature-dependent expression of flagella in Legionella. J Gen Microbiol (1991) 1.22
Characterization of the beta-lactamases of six species of Legionella. J Bacteriol (1982) 1.20
Aggregation substance increases adherence and internalization, but not translocation, of Enterococcus faecalis through different intestinal epithelial cells in vitro. Infect Immun (2000) 1.19
Pharmacodynamics of levofloxacin and ciprofloxacin in a murine pneumonia model: peak concentration/MIC versus area under the curve/MIC ratios. Antimicrob Agents Chemother (2003) 1.17
Renal tolerance and pharmacokinetics of vancomycin in rats. J Antimicrob Chemother (1984) 1.17
O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections. Clin Diagn Lab Immunol (1997) 1.17
Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun (1996) 1.17
Moxifloxacin prophylaxis in neutropenic patients. J Antimicrob Chemother (2006) 1.16
Hemagglutinating and adherence properties of Staphylococcus saprophyticus: epidemiology and virulence in experimental urinary tract infection of rats. FEMS Microbiol Immunol (1988) 1.15
The structure of the O-specific chain of Legionella pneumophila serogroup 1 lipopolysaccharide. Eur J Biochem (1994) 1.14
Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers. Antimicrob Agents Chemother (1996) 1.12
CAPNETZ-community-acquired pneumonia competence network. Infection (2004) 1.11
[SARS--Severe Acute Respiratory syndrome]. Pneumologie (2003) 1.09
De novo synthesis of Legionella pneumophila antigens during intracellular growth in phagocytic cells. Infect Immun (1996) 1.06
Bacterial colonization and endotoxin contamination of intravenous infusion fluids. J Hosp Infect (1997) 1.06
Cloning, genetic analysis, and nucleotide sequence of a determinant coding for a 19-kilodalton peptidoglycan-associated protein (Ppl) of Legionella pneumophila. Infect Immun (1991) 1.04
Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysis. Infection (1999) 1.04
Differential expression of interleukin-6, intracellular adhesion molecule 1, and major histocompatibility complex class II molecules in renal carcinoma cells stimulated with S fimbriae of uropathogenic Escherichia coli. Infect Immun (1993) 1.04
Experimental studies on nephrotoxicity and pharmacokinetics of LY 146032 (daptomycin) in rats. J Antimicrob Chemother (1990) 0.99
Diagnosis of ornithosis by cell culture and polymerase chain reaction in a patient with chronic pneumonia. Clin Infect Dis (1995) 0.99
Protective effect of antilipopolysaccharide monoclonal antibody in experimental Klebsiella infection. Infect Immun (1997) 0.99
Mycetoma due to Exophiala jeanselmei and Mycobacterium chelonae in a 73-year-old man with idiopathic CD4+ T lymphocytopenia. Mycoses (1996) 0.99
Use of a receiver operating characteristic in the evaluation of two commercial enzyme immunoassays for detection of Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis (1994) 0.98
Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics. J Antimicrob Chemother (1998) 0.97
[S3-guideline on ambulant acquired pneumonia and deep airway infections]. Pneumologie (2005) 0.97
Steady-state pharmacokinetics of rufloxacin in elderly patients with lower respiratory tract infections. Ther Drug Monit (1992) 0.96
Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product. Clin Exp Immunol (1998) 0.96
Aggregation substance-mediated adherence of Enterococcus faecalis to immobilized extracellular matrix proteins. Microb Pathog (2001) 0.95
Identification and characterization of a surface-associated protein (Ssp) of Staphylococcus saprophyticus. Infect Immun (1992) 0.94
Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity. Infect Immun (2001) 0.94
Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany. Clin Microbiol Infect (2007) 0.93
A fatal infection with Alternaria alternata and Aspergillus terreus in a child with agranulocytosis of unknown origin. Mycoses (1995) 0.93
Evaluation of a competitive ELISA method for the determination of Klebsiella O antigens. J Med Microbiol (1996) 0.93
Rapid and standardized detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR. Eur J Clin Microbiol Infect Dis (2003) 0.92
Identification of 27-oxo-octacosanoic acid and heptacosane-1,27-dioic acid in Legionella pneumophila. FEMS Microbiol Lett (1992) 0.91
A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. Antimicrob Agents Chemother (1994) 0.91
Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia. J Antimicrob Chemother (2009) 0.90
Growth in serum-free medium improves isolation of Chlamydia pneumoniae. J Clin Microbiol (1993) 0.89
Genetics of Escherichia coli uropathogenicity: analysis of the O6:K15:H31 isolate 536. Zentralbl Bakteriol (1992) 0.89
High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study. Microb Drug Resist (1997) 0.89
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. Scand J Gastroenterol (1999) 0.89
Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases. Am J Gastroenterol (1992) 0.89
Endocarditis caused by Bacillus circulans. Infection (1992) 0.89
Legionella pneumophila infection in intratracheally inoculated T cell-depleted or -nondepleted A/J mice. J Immunol (1998) 0.88
Age-dependent nephrotoxicity and the pharmacokinetics of gentamicin in rats. Eur J Pediatr (1980) 0.87
Aggregation substance promotes colonic mucosal invasion of Enterococcus faecalis in an ex vivo model. J Surg Res (2000) 0.87
[Animal studies on antibacterial activity of 10 cephalosporins (author's transl)]. Zentralbl Bakteriol Orig A (1978) 0.87
The microbiological efficacy of the combination of fosfomycin and vancomycin against clinically relevant staphylococci. Infection (1989) 0.86
Adherence to and cytotoxicity of Escherichia coli for eucaryotic cell lines quantified by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide). Zentralbl Bakteriol (1992) 0.86
Interaction of fibronectin and aggregation substance promotes adherence of Enterococcus faecalis to human colon. Dig Dis Sci (2002) 0.86
Characterization of the Legionella pneumophila gene ligA. Int J Med Microbiol (2000) 0.86
Experimental investigations of cefuroxime in renal tolerance and therapeutic efficacy in pyelonephritis. Proc R Soc Med (1977) 0.86
Prevalence of the internalization-associated gene prtF1 in a bacterial population of Streptococcus pyogenes isolated from children with acute pharyngotonsillitis before and after antibiotic therapy. Microb Drug Resist (2004) 0.85
Subtyping of Legionella pneumophila serogroup 1 strains isolated in Germany using monoclonal antibodies. Zentralbl Bakteriol (1992) 0.85
Influence of cloned tRNA genes from a uropathogenic Escherichia coli strain on adherence to primary human renal tubular epithelial cells and nephropathogenicity in rats. Infect Immun (1996) 0.85
Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania. Microb Drug Resist (1997) 0.85
Influence of fosfomycin and tobramycin on vancomycin-induced nephrotoxicity. Infection (1985) 0.84
Procalcitonin, C-reactive protein, interleukin-6, and soluble intercellular adhesion molecule-1 as markers of postoperative orthopaedic joint prosthesis infections. Int J Immunopathol Pharmacol (2011) 0.84
In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob Agents Chemother (1995) 0.84
[Animal studies on nephrotoxicity of seven aminoglycoside antibiotics during long-term treatment (author's transl)]. Arzneimittelforschung (1979) 0.84
Comparative evaluation of synergy of combinations of beta-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae. J Antimicrob Chemother (2011) 0.84
A model of genital Chlamydia trachomatis infection using human xenografts in severe combined immunodeficiency mice. Infect Immun (1996) 0.84
Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation. Clin Diagn Lab Immunol (1999) 0.84
[Animal experiments on the nephrotoxicity, pharmacokinetics and therapeutic efficacy of dibekacin]. Arzneimittelforschung (1981) 0.83
Experimental studies on the nephrotoxicity of amphotericin B in rats. J Antimicrob Chemother (1991) 0.83
Influence of R-plasmid mediated beta-lactamase production on the therapeutic efficacy of cefoxitin and cefamandole in experimental chemotherapy. J Antimicrob Chemother (1980) 0.83
How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia. Eur Respir J (2010) 0.83
Clearance of Chlamydia trachomatis-induced polyserositis in SCID mice requires both CD4+ and CD8+ cells. Med Microbiol Immunol (1998) 0.82
Fungaemia due to Candida pelliculosa in a case of acute pancreatitis. Mycoses (1993) 0.82
Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia. J Infect (2011) 0.82
Transverse myelitis as a first manifestation of systemic lupus erythematosus: a case report. Lupus (1995) 0.81
Diagnostic value of bronchoalveolar lavage in patients with opportunistic and nonopportunistic bacterial pneumonia. Infection (1994) 0.81